Results 11 to 20 of about 785,500 (213)
Donor-derived invasive aspergillosis after kidney transplant [PDF]
Medical Mycology Case Reports, 2018 The risk of transmission of infectious diseases from allograft to recipient is well known. Viruses and bacteria are the most frequent causes of transmissible infections.
Maricela Valerio +9 more
doaj +3 more sources
Delayed Diagnosis of a Diffuse Invasive Gastrointestinal Aspergillosis in an Immunocompetent Patient [PDF]
Case Reports in Critical Care, 2020 Invasive aspergillosis represents a clinical picture frequently associated with host’s immunosuppression which usually involves a high morbidity and mortality.
S. Guglielmetti +6 more
doaj +3 more sources
Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis [PDF]
Medical Mycology Case Reports, 2018 Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in non-cirrhotic patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Jon G. Persichino +4 more
doaj +2 more sources
Treatment of invasive aspergillosis
Journal of Infection, 1994 Invasive aspergillosis is generally a life-threatening invasive opportunistic mycosis affecting principally the upper and lower respiratory tract. Therapeutic response rates vary considerably from one host group to another with particularly high mortality rates in bone marrow transplant, liver transplant and patients with aplastic anaemia or AIDS. Only
Denning, D.W.; id_orcid
openaire +3 more sources
Invasive Aspergillosis in Transplant Recipients
Medicine, 1999 Infections and rejection have long been the leading causes of morbidity and mortality in transplant recipients. Although recent advances in immunosuppression, prophylaxis, and treatment of infections such as cytomegalovirus have resulted in improved outcome in transplant recipients, invasive aspergillosis remains a scourge of transplantation medicine ...
Paterson, David L., Singh, Nina
openaire +6 more sources
Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™ [PDF]
, 2011 Background: Despite advances in the treatment, the morbidity and mortality rate associated with invasive aspergillosis remains unacceptably high (70–90%) in immunocompromised patients.
M N V Ravi Kumar +20 more
core +5 more sources
Treatment Of Invasive Aspergillosis [PDF]
Namık Kemal Tıp Dergisi, 2018 Invasive aspergillosis (IA) is an infectious disease caused by Aspergillus species, is usually seen in patients with immune deficiency and has been associated with high mortality rate.
İlknur ERDEM +4 more
doaj +1 more source
Medical Mycology, 2000 Acute invasive aspergillosis (IA) is a devastating disease. Early diagnosis allowing an early treatment may improve the prognosis. However, this goal remains difficult to achieve. When diagnosis is confirmed it is often already too late. Galactomannan antigen detection and DNA detection are under clinical evaluation to improve early diagnosis and ...
Verweij, P.E. +6 more
openaire +4 more sources
Invasive Pulmonary Aspergillosis
Journal of Fungi, 2023 Invasive pulmonary aspergillosis is growing in incidence, as patients at risk are growing in diversity. Outside the classical context of neutropenia, new risk factors are emerging or newly identified, such as new anticancer drugs, viral pneumonias and hepatic dysfunctions. Clinical signs remain unspecific in these populations and the diagnostic work-up
Marie-Pierre Ledoux, Raoul Herbrecht
openaire +3 more sources
Clinical periodontal diagnosis
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source